Accelerated in-stent restenosis after bare-metal stenting of a myocardial bridge and successful treatment with drug-eluting stenting.
Stenting of symptomatic myocardial bridges is a therapeutic option with documented good short-term outcome. However, limited data on the long term outcome of myocardial bridge stenting has shown a higher restenosis rate comparing to stenting of de novo atherosclerotic lesions. Drug-eluting stenting of de novo atherosclerotic lesions has reduced the rate of restenosis comparing to bare metal stenting, but there is no available data on drug-eluting myocardial bridge stenting. We present a case of accelerated in-stent restenosis after bare-metal myocardial bridge stenting, successfully treated with drug-eluting stenting.
Ziakas
A
A
1st Department of Cardiology, AHEPA University Hospital, Thessaloniki, Greece. aziakas@med.auth.gr
Gavrilidis
S
S
Parisiadou
A
A
Parxaridis
G
G
D000328:Adult; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000209:etiology / Q000628:therapy; D054855:Drug-Eluting Stents; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008670:Metals; D009203:Myocardial Infarction / Q000628:therapy*; D015607:Stents / Q000009:adverse effects*; D013997:Time Factors; D016896:Treatment Outcome
D008670:Metals